Evidence map›Paper›PMID 40983653›Full record

ArticleActa pharmacologica Sinica2026

Editorial Expression of Concern: n-Butylidenephthalide induced apoptosis in the A549 human lung adenocarcinoma cell line by coupled down-regulation of AP-2α and telomerase activity.

Chyou-Wei Wei, Chai-Ching Lin, Yung-Luen Yu, Chai-Yi Lin, Po-Cheng Lin, Min-Tze Wu, Cheng-Jueng Chen, Wen-Liang Chang, Shinn-Zong Lin, Yi-Lin Sophia Chen and 1 more

Abstract readExpression of Concern
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmacologica Sinica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Chyou-Wei Wei *Institute of Biomedical Nutrition, College of Medicines and Nursings, Hungkuang University, Taichung, Taiwan, China.
Chai-Ching Lin *Graduate Institute of Biotechnology, National Ilan University Ilan, Ilan, Taiwan, China.
Yung-Luen Yu *Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University and Hospital, Taichung, Taiwan, China.
Chai-Yi LinGraduate Institute of Biotechnology, National Ilan University Ilan, Ilan, Taiwan, China.
Po-Cheng LinGraduate Institute of Biotechnology, National Dong Hwa University, Hualien, Taiwan, China.
Min-Tze WuBiotechnology Division, Taiwan Agricultural Research Institute Council of Agriculture, Taichung, Taiwan, China.
Cheng-Jueng ChenDivision of Traumatology, Department of Surgery; Tri-Service General Hospital, Taipei, Taiwan, China.
Wen-Liang ChangSchool of Pharmacy, National Defense Medical Center, Taipei, Taiwan, China.
Shinn-Zong LinCenter for Neuropsychiatry, China Medical University and Hospital, Taichung, Taiwan, China.
Yi-Lin Sophia ChenGraduate Institute of Biotechnology, National Ilan University Ilan, Ilan, Taiwan, China. a221865880@yahoo.com.tw.
Horng-Jyh HarnDepartment of Pathology, China Medical University and Hospital, Taichung, Taiwan, China. d15977@mail.cmuh.org.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40983653
PMCPMC12764920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.